Contract Notice Detail

Summary Information Summary Information Forbid offers above base price:   Request Reference: 31/49/2024   Request Name: Medicamentos Darunavir+ Cobicistate + Emtricitabina + Tenofovir Alafenamida   Phase: Tendering Phase State: Awarded Description: 31/49/2024 - Medicamentos Darunavir+ Cobicistate + Emtricitabina + Tenofovir Alafenamida   Procedure Type: VortalGOV - Acquisition under a Framework Agreement (via Direct Award)   Lot Name Lot Base Price Expected Duration D542 - DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] 1 (Years) D559 - DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP] 1 (Years) Object of the Contract Object of the Contract Type of Contract: Supplies Acquisition   Main Object CPV Main Category: Rua Leão Penedo União das freguesias de Faro (Sé e São Pedro) Faro PORTUGAL   CPV Main Vocabulary 33600000-6 - Pharmaceutical products   CPV Supplementary Vocabulary   Additional Classifications List   Scheduling Scheduling Request online publishing date: 1/17/2024 11:52 AM (UTC 0 hours)   National official publishing date and time (DR): 1/19/2022 12:00 AM (UTC 0 hours)   Due datetime for receiving replies: 1/18/2024 5:00 PM (UTC 0 hours)   Financial Settings Financial Settings Define Advance Payments? No   Define Warranties? No   Contract Documents Contract Documents Document Name Description Doc Classification 31000000492024.xlsx 31000000492024.xlsx Download convite 258º.pdf convite 258º.pdf Download Object of contract This contract is subject to renewal? No   The procurement is related to a project and/or programme financed by European Union funds? No   Legal, economic, financial and technical information The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons? No   Questionnaire Questionnaire     1   Questionário   1.1       Lote 1 Section for Lot - D542 - DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP]   1.1.1       Lote 1 Bill of Quantities * (Os valores indicados não incluem o IVA) Solicitou requisitos adicionais nesta lista de preços.           Preço Total Total without VAT0,000000 EUR             Cód. Artigo Referência Interna Descrição Qt Unidade Preço Unitário Preço Total           ReferenceD542 Internal Reference DescriptionDARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] Qty4 500,000000 UnitUN Price per Unit Total   Comentários do Comprador:500189412 | Janssen - Cilag Farmacêutica, Lda. | CPA:2022040/74/0088 | NºAIM:5630702;       1.2       Lote 2 Section for Lot - D559 - DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP]   1.2.1       Lote 2 Bill of Quantities * (Os valores indicados não incluem o IVA) Solicitou requisitos adicionais nesta lista de preços.           Preço Total Total without VAT0,000000 EUR             Cód. Artigo Referência Interna Descrição Qt Unidade Preço Unitário Preço Total           ReferenceD559 Internal Reference DescriptionDARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP] Qty13 140,000000 UnitUN Price per Unit Total   Comentários do Comprador:500189412 | Janssen - Cilag Farmacêutica, Lda. | CPA:2022040/74/0089 | NºAIM:5728373;     Evaluation Evaluation Evaluation General Settings Evaluation General Settings Evaluation guideline MostEconomicallyAdvantageousTender   Evaluation Method Manual   Evaluation Items Evaluation Items Name Lot Regras de avaliação para o lote 1 1 - D542 - DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] Regras de avaliação para o lote 2 2 - D559 - DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP]   Critérios de Adjudicação     Peso (%)**   1   Preço 100   Define tie breaking rules? YesNo     Critérios de Adjudicação     Peso (%)**   1   Preço 100   Define tie breaking rules? YesNo     Public Messages Public Messages Type Reference Subject Date No items found...